HMGB1 and brain ischemia: We found that treatment with Hp significantly improved the neurological deficit and motor dysfunction after cerebral ischemia by inhibiting systemic elevation of HMGB1, indicating that HMGB1 is a therapeutic target for the neuroinflammatory stage after cerebral ischemia and that Hp ameliorates ischemic brain damage by inhibiting systemic elevation of HMGB1.